Our TEPI technology comprises a novel adhesive into which the drug to be delivered is mixed. The adhesive has been developed by Medherant and was well-tolerated in a Phase I clinical trial. The adhesive has properties that enable us to produce thin, flexible and attractive patches that stick well but are easy to remove.
Key benefits of our technology
![Scientists looking at sample](/sites/default/files/images/high-payload.jpg?a=201901)
High payload
Up to 50wt% achieved for drug and excipients
- Enables transdermal delivery of lower potency drugs
- Extended release (up to 7 days) formulations can be developed
- Smaller and more discrete patch can be produced
![Patch adhesion test](/sites/default/files/images/better-adhesion.jpg?a=201901)
Better adhesion
Sticks even when wet
- Full dose delivered as entire patch remains in contact with the skin
- No cold-flow of adhesive around the edges of the patch
- Easy and painless to remove like a sticking plaster
![Scientific equipment](/sites/default/files/images/other-benefits.jpg?a=201901)
Other Benefits
Flexibility to optimise delivery
- Efficient release of drug
- Less residual drug in the patch on removal
- Rates of flux can be customised to achieve desired product profile
- Solvent-free manufacturing process